Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,085,290
+$1,209,289 QoQ
Shares Held
408,529
+35.2% QoQ
Ownership
0.160%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 316 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names. BCRX ranks #25 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
1,267,706 | $101,074,198 | |
| 2 | ALKS |
Alkermes plc.
|
1,312,031 | $68,750,423 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,804,758 | $61,813,683 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
1,950,332 | $49,479,922 | |
| 5 | ZTS |
Zoetis Inc.
|
537,515 | $38,625,827 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
569,756 | $36,435,896 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
767,668 | $35,704,237 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,049,467 | $32,852,956 |
All Filings in BCRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,085,290 | 408,529 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,876,001 | 302,101 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,730,234 | 1,247,466 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $12,973,859 | 1,709,336 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $39,329,713 | 4,389,477 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,918,340 | 1,589,112 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,370,777 | 315,263 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,741,084 | 229,090 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,167,943 | 350,800 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $172,090 | 33,876 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $183,479 | 30,631 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $73,237 | 10,403 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,115,249 | 133,723 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,121,744 | 533,253 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,243,790 | 495,539 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $8,439,753 | 519,050 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $15,681,870 | 1,132,265 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $13,975,313 | 972,534 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,794,636 | 872,526 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $618,366 | 60,803 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $325,118 | 43,640 | Shares | Defined | 2021-02-16 | |
| 2020-03-31 | $73,440 | 36,720 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||